MALVERN, PA — YPrime, a leading provider of electronic clinical outcomes assessment (eCOA) platforms, has released the results of a comprehensive survey examining the experiences and perspectives of clinical stakeholders in regard to eCOA. The study provides an insightful look into the growing adoption of eCOA in clinical trials, revealing some of the primary concerns and measures of success for industry professionals.
The surge in the implementation of eCOA in clinical studies is primarily fueled by its multiple advantages, such as enhanced data accuracy, improved participant compliance, and more efficient study processes. However, the transition has not been without its challenges.
According to YPrime’s research, the top issues causing worry among clinical professionals include timelines and delays (62%), data change capabilities (50%), and protocol amendments (41%). Over the past 18 months, the majority of respondents reported having made between one to three protocol amendments (52%), while a significant number made between four to six amendments (35%), and a smaller group reported making seven or more amendments (13%).
When asked about the key indicators of success in eCOA endpoint collection, respondents pointed to visit compliance status (79%), diary or scale compliance status (77%), and patient enrollment status (65%). These findings suggest that the focus in the industry is shifting towards operational efficiency, data integrity, and patient engagement.
Commenting on the survey results, Mike Hughes, YPrime’s Chief Product Officer, said, “The insights from our eCOA research reflect the industry’s current focus and future direction. We are excited to share these perspectives as they will help shape the evolution of our platforms to better meet the changing needs of patients, clinical sites, and sponsors.”
YPrime’s survey offers a deep dive into the concerns, preferences, and success metrics of clinical stakeholders in relation to eCOA endpoint collection. The findings provide a roadmap for more efficient clinical trials and highlight the need for ongoing innovation in eCOA platforms.
The full report, titled ‘eCOA Trends for Today and Tomorrow’, is available for download, offering invaluable insights for those in the pharmaceutical industry seeking to understand the evolving landscape of eCOA in clinical research.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.